D’Mello, S. R. (2021). When Good Kinases Go Rogue: GSK3, p38 MAPK and CDKs as Therapeutic Targets for Alzheimer’s and Huntington’s Disease. Int J Mol Sci.
Styl cytowania ChicagoD’Mello, Santosh R. "When Good Kinases Go Rogue: GSK3, P38 MAPK and CDKs As Therapeutic Targets for Alzheimer’s and Huntington’s Disease." Int J Mol Sci 2021.
Styl cytowania MLAD’Mello, Santosh R. "When Good Kinases Go Rogue: GSK3, P38 MAPK and CDKs As Therapeutic Targets for Alzheimer’s and Huntington’s Disease." Int J Mol Sci 2021.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..